ReviewPakistan journal of medical sciences2025
Ustekinumab versus vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor: A systematic review and meta-analysis.
Jianfeng Dai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.